GlucoTrack Inc. (GCTK)
0.17
-0.03 (-17.07%)
At close: Mar 31, 2025, 11:13 AM
Company Description
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally.
It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
GlucoTrack Inc.

Country | IL |
IPO Date | Apr 25, 2013 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 6 |
CEO | Paul V. Goode Ph.D. |
Contact Details
Address: 8 Ariel Sharon Street Or Yehuda, IL | |
Website | https://www.glucotrack.com |
Stock Details
Ticker Symbol | GCTK |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001506983 |
CUSIP Number | 45824Q507 |
ISIN Number | US45824Q5071 |
Employer ID | 98-0668934 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Paul V. Goode Ph.D. | Chief Executive Officer, President & Director |
Peter C. Wulff | Chief Financial Officer |
Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board |
David Malka BA | Co-Founder |
Drinda Benjamin | Vice President of Marketing |
Mark Tapsak Ph.D. | Chief Scientific Officer |
Vincent Wong | Vice President of Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 28, 2025 | 4 | Filing |
Mar 28, 2025 | 4 | Filing |
Mar 28, 2025 | 4 | Filing |
Mar 28, 2025 | 4 | Filing |
Mar 28, 2025 | 3 | Filing |
Mar 28, 2025 | 3 | Filing |
Mar 28, 2025 | 3 | Filing |
Mar 19, 2025 | 8-K | Current Report |
Mar 13, 2025 | 8-K | Current Report |
Feb 26, 2025 | 8-K | Current Report |